For help on how to get the results you want, see our search tips.
1727 results
-
List item
Human medicine European public assessment report (EPAR): Epidyolex (updated)
Cannabidiol, Lennox Gastaut Syndrome, Epilepsies, Myoclonic
Date of authorisation: 19/09/2019,
, Revision: 4, Authorised, Last updated: 18/09/2020
-
List item
Human medicine European public assessment report (EPAR): Xeljanz (updated)
tofacitinib citrate, Arthritis, Rheumatoid
Date of authorisation: 21/03/2017,
Date of refusal: 25/04/2013,
, 
, Revision: 12, Authorised, Last updated: 18/09/2020
-
List item
Veterinary medicine European public assessment report (EPAR): Respiporc FLUpan H1N1 (updated)
Influenza A virus/humanstrain: A/Jena/VI5258/2009 (H1N1)pdm09, inactivated, Pigs
Date of authorisation: 17/05/2017, Revision: 5, Authorised, Last updated: 18/09/2020 -
List item
Human medicine European public assessment report (EPAR): Sildenafil Actavis (updated)
sildenafil, Erectile Dysfunction
Date of authorisation: 10/12/2009,
, Revision: 13, Authorised, Last updated: 18/09/2020
-
List item
Human medicine European public assessment report (EPAR): Apidra (updated)
insulin glulisine, Diabetes Mellitus
Date of authorisation: 27/09/2004, Revision: 29, Authorised, Last updated: 18/09/2020 -
List item
Veterinary medicine European public assessment report (EPAR): Respiporc Flu3 (updated)
inactivated influenza-A virus / swine, Pigs
Date of authorisation: 14/01/2010, Revision: 4, Authorised, Last updated: 18/09/2020 -
List item
Human medicine European public assessment report (EPAR): Truvada (updated)
emtricitabine, tenofovir disoproxil fumarate, HIV Infections
Date of authorisation: 20/02/2005, Revision: 43, Authorised, Last updated: 17/09/2020 -
List item
Human medicine European public assessment report (EPAR): Ruxience (updated)
rituximab, Leukemia, Lymphocytic, Chronic, B-Cell, Arthritis, Rheumatoid, Microscopic Polyangiitis, Pemphigus
Date of authorisation: 01/04/2020,, 
, Revision: 2, Authorised, Last updated: 17/09/2020
-
List item
Human medicine European public assessment report (EPAR): Bortezomib Sun (updated)
bortezomib, Multiple Myeloma
Date of authorisation: 22/07/2016,, Revision: 8, Authorised, Last updated: 17/09/2020
-
List item
Human medicine European public assessment report (EPAR): Hizentra (updated)
human normal immunoglobulin (SCIg), Immunologic Deficiency Syndromes
Date of authorisation: 14/04/2011, Revision: 20, Authorised, Last updated: 16/09/2020 -
List item
Human medicine European public assessment report (EPAR): Arsenic trioxide Accord (updated)
Arsenic trioxide, Leukemia, Promyelocytic, Acute
Date of authorisation: 14/11/2019,, Revision: 2, Authorised, Last updated: 16/09/2020
-
List item
Human medicine European public assessment report (EPAR): Myocet liposomal (previously Myocet) (updated)
doxorubicin hydrochloride, Breast Neoplasms
Date of authorisation: 13/07/2000, Revision: 22, Authorised, Last updated: 16/09/2020 -
List item
Human medicine European public assessment report (EPAR): Votubia (updated)
everolimus, Tuberous Sclerosis
Date of authorisation: 02/09/2011,, Revision: 27, Authorised, Last updated: 16/09/2020
-
List item
Human medicine European public assessment report (EPAR): Tolura (updated)
telmisartan, Hypertension
Date of authorisation: 04/06/2010,, Revision: 9, Authorised, Last updated: 16/09/2020
-
List item
Human medicine European public assessment report (EPAR): Kigabeq (updated)
vigabatrin, Spasms, Infantile, Epilepsies, Partial
Date of authorisation: 20/09/2018, Revision: 3, Authorised, Last updated: 16/09/2020 -
List item
Human medicine European public assessment report (EPAR): Eliquis (updated)
Apixaban, Arthroplasty, Venous Thromboembolism
Date of authorisation: 18/05/2011,, Revision: 22, Authorised, Last updated: 16/09/2020
-
List item
Human medicine European public assessment report (EPAR): Visudyne (updated)
verteporfin, Myopia, Degenerative, Macular Degeneration
Date of authorisation: 27/07/2000, Revision: 35, Authorised, Last updated: 16/09/2020 -
List item
Human medicine European public assessment report (EPAR): Azacitidine Mylan (updated)
azacitidine, Myelodysplastic Syndromes, Leukemia, Myelomonocytic, Chronic, Leukemia, Myeloid, Acute
Date of authorisation: 27/03/2020,, Revision: 1, Authorised, Last updated: 16/09/2020
-
List item
Human medicine European public assessment report (EPAR): Rebif (updated)
interferon beta-1a, Multiple Sclerosis
Date of authorisation: 03/05/1998, Revision: 38, Authorised, Last updated: 16/09/2020 -
List item
Human medicine European public assessment report (EPAR): Lixiana (updated)
edoxaban tosylate, Stroke, Venous Thromboembolism
Date of authorisation: 19/06/2015,, Revision: 12, Authorised, Last updated: 16/09/2020
-
List item
Human medicine European public assessment report (EPAR): Roteas (updated)
edoxaban tosylate, Stroke, Venous Thromboembolism
Date of authorisation: 19/04/2017,, Revision: 6, Authorised, Last updated: 16/09/2020
-
List item
Human medicine European public assessment report (EPAR): Hemlibra (updated)
Emicizumab, Hemophilia A
Date of authorisation: 23/02/2018,, 
, Revision: 6, Authorised, Last updated: 16/09/2020
-
List item
Human medicine European public assessment report (EPAR): Ebilfumin (updated)
oseltamivir, Influenza, Human
Date of authorisation: 22/05/2014,, Revision: 12, Authorised, Last updated: 16/09/2020
-
List item
Veterinary medicine European public assessment report (EPAR): Poulvac E. coli (updated)
Live aroA gene deleted Escherichia coli, type 078, strain EC34195, Chicken, Turkeys
Date of authorisation: 15/06/2012, Revision: 9, Authorised, Last updated: 16/09/2020 -
List item
Human medicine European public assessment report (EPAR): Peyona (previously Nymusa) (updated)
Caffeine citrate, Apnea
Date of authorisation: 02/07/2009, Revision: 10, Authorised, Last updated: 16/09/2020